[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567473":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":36,"responsibleParty":82,"collaborators":86,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":10,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":97,"minAge":98,"maxAge":10,"enrollmentInfo":99,"targetDuration":10,"studyType":102,"phases":10,"briefSummary":103,"conditions":104,"keywords":108,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Jagiellonian University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients",null,"Both sexes, aged 18 or older. The group will include 80 patients with multiple sclerosis, 80 patients with amyotrophic lateral sclerosis and 50 survivors of ischemic stroke",[13],"Diagnostic Test: Testing with Questionnaires",{"label":15,"type":10,"description":16,"interventionNames":17},"Control","Both sexes, aged 18 or older. The group will include 100 healthy controls.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DIAGNOSTIC_TEST","Testing with Questionnaires","Testing with following Questionnaires: pFSS, Polish-language version of Modified Fatigue Impact Scale, Visual Analogue Scale of Fatigue, EQ-5D-5L (EuroQol-5 dimension) questionnaire, Beck Depression Inventory II. In randomly selected 30 patients and 20 controls questionnaires will be administered twice with two weeks interval to assess the test-retest reliability.",[15,9],[25],{"name":26,"affiliation":5,"role":27},"Jakub M Antczak, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","+48 12 400 25 50","jakub.antczak@uj.edu.pl",{"name":34,"role":30,"phone":31,"phoneExt":10,"email":35},"Gabriela G Rusin, MD","gabriela.rusin@alumni.uj.edu.pl",[37,64],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Jagiellonian University Medical College, Department of Neurology","RECRUITING","Krakow","Lesser Poland Voivodeship","31503","Poland","PL",{"type":46,"coordinates":47},"Point",[48,49],19.93658,50.06143,{"lat":49,"lon":48},[52,54,58,61,63],{"name":26,"role":30,"phone":53,"phoneExt":10,"email":32},"+48 795 421 153",{"name":55,"role":30,"phone":56,"phoneExt":10,"email":57},"Gabriela Rusin, MD","+48 601 661 607","gabriela.rusin@doctoral.uj.edu.pl",{"name":59,"role":60,"phone":10,"phoneExt":10,"email":10},"Magdalena Spaczyńska-Boczar, MD","SUB_INVESTIGATOR",{"name":62,"role":60,"phone":10,"phoneExt":10,"email":10},"Marcin Wnuk, MD",{"name":34,"role":60,"phone":10,"phoneExt":10,"email":10},{"facility":65,"status":39,"city":66,"state":10,"zip":67,"country":43,"countryCode":44,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Institute of Psychiatry and Neurology","Warsaw","02957",{"type":46,"coordinates":69},[70,71],21.01178,52.22977,{"lat":71,"lon":70},[74,78],{"name":75,"role":30,"phone":76,"phoneExt":10,"email":77},"Marzena Ułamek-Kozioł","+48 22 45 82 540","mulamek@ipin.edu.pl",{"name":79,"role":30,"phone":80,"phoneExt":10,"email":81},"Bogdan Stefanowski, MD","+48 22 45 82 532","bstefanowski@ipin.edu.pl",{"type":83,"investigatorFullName":84,"investigatorTitle":85,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Jakub Antczak","Principal Investigator",[87],{"name":88,"class":6},"Institute of Psychiatry and Neurology, Warsaw","100567473","polish-version-fatigue-severity-scale-100567473",false,"NCT06668649","Polish Version Fatigue Severity Scale","Validation of Polish Language Version of Fatigue Severity Scale","Inclusion Criteria:\n\n* Diagnosis of definite multiple sclerosis or definite, laboratory-supported multiple sclerosis, or definite amyotrophic lateral sclerosis, or probable amyotrophic lateral sclerosis or probable, laboratory supported amyotrophic lateral sclerosis or ischemic stroke or - for healthy controls - lack of diseases, pharmacotherapy or habits, which could induce abnormal tiredness\n\nExclusion Criteria:\n\n* Presence of cognitive deficits or behavioral disorder, which could disturb participation in the study.",true,"ALL","18 Years",{"count":100,"type":101},310,"ESTIMATED","OBSERVATIONAL","Fatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis and other diseases with profound effect on quality of life and professional and social functioning. Not infrequent it is misdiagnosed as sleepiness or other symptom. Fatigue severity scale is a time efficient and easy to apply instrument to assess the impact of fatigue on patient's life. The aim of this study is to validate the Polish-language version of the Fatigue Severity Scale.",[105,106,107],"Multiple Sclerosis","Amyotrophic Lateral Sclerosis","Stroke, Ischemic",[109,105,110,111],"Fatigue","stroke","quality of life","2024-11-07",{"date":114,"type":115},"2024-11-08","ACTUAL",{"date":117,"type":115},"2024-11-04",{"date":119,"type":101},"2027-03-31",{"name":84,"class":6},2]